000 | 01120 a2200301 4500 | ||
---|---|---|---|
005 | 20250512042928.0 | ||
264 | 0 | _c19890602 | |
008 | 198906s 0 0 eng d | ||
022 | _a0724-8741 | ||
024 | 7 |
_a10.1023/a:1015927004752 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAmidon, G L | |
245 | 0 | 0 |
_aEstimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. _h[electronic resource] |
260 |
_bPharmaceutical research _cOct 1988 |
||
300 |
_a651-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCefatrizine _xpharmacokinetics |
650 | 0 | 4 | _aCell Membrane Permeability |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntestinal Absorption |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 | _aRats |
700 | 1 | _aSinko, P J | |
700 | 1 | _aFleisher, D | |
773 | 0 |
_tPharmaceutical research _gvol. 5 _gno. 10 _gp. 651-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1023/a:1015927004752 _zAvailable from publisher's website |
999 |
_c3250398 _d3250398 |